By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


ZS Pharma 

508 Wrangler Drive
Suite 100
Coppell  Texas  75019  U.S.A.
Phone: 650-458-4100 Fax: 650-458-0084



Company News
ZS Pharma (ZSPH) To Present Late-Breaking Abstract Data From Phase 3 Trial Of ZS-9 In State Of The Art And Featured Research Session Oral Presentation At European Society of Cardiology Congress 8/26/2014 7:19:02 AM
ZS Pharma (ZSPH) Announces Second Quarter 2014 Financial Results 8/15/2014 8:01:03 AM
ZS Pharma (ZSPH) Secures $20 Million In Debt Financing 7/17/2014 6:43:17 AM
ZS Pharma (ZSPH) Completes Patient Enrollment In ZS004, Its Second Phase 3 Study Of ZS-9 In Patients With Hyperkalemia 7/15/2014 5:58:09 AM
ZS Pharma (ZSPH) Announces Allowance Of Two U.S. Patent Applications For ZS-9 7/8/2014 6:25:26 AM
ZS Pharma (ZSPH) Announces Start Of Enrollment Of Phase 3 Long-Term Maintenance Study Of ZS-9 In Patients With Hyperkalemia 6/26/2014 8:54:51 AM
ZS Pharma (ZSPH) Announces Closing Of Initial Public Offering And Full Exercise Of Underwriters’ Over-Allotment Option 6/24/2014 10:37:02 AM
ZS Pharma (ZSPH) Announces Pricing Of Initial Public Offering 6/18/2014 11:08:38 AM
ZS Pharma To Present Data From Phase 3 Trial Of ZS-9 As Late-Breaking Oral Presentation At 2014 American Society of Hypertension (ASH) Annual Scientific Meeting 5/19/2014 6:41:07 AM
ZS Pharma (ZSPH) Swings For $86 Million IPO 5/15/2014 9:13:40 AM